ASUS & Brain Tunnelgenix Technologies

16-Oct-2010 | News-Press Release

American Society of Anesthesiologists Annual Meeting, San Diego, CA (October 16, 2010) - ASUS® and Brain Tunnelgenix Technologies Corp.™(btt™Corp.), of Bridgeport, CT, have established a partnership to deliver the first personal computer-based temperature monitoring system approved by the U.S. Food and Drug Administration. Specifically designed to be used during surgical procedures, in the recovery room, in intensive care and for general patient monitoring, the new Abreu btt™ 700 System for continuous temperature monitoring incorporates an ASUS Eee PC 1005HA as a key component.

The Abreu btt 700 System is the world’s first continuous and noninvasive device that measures temperature on the skin surface of the body with the highest thermoconductivity, the fat-free skin that overlies the Brain Temperature Tunnel (BTT), a new thermal organ in the body discovered in groundbreaking research by Dr. Marc Abreu of Yale University.

American Society of Anesthesiologists Annual Meeting, San Diego, CA (October 16, 2010) - ASUS® and Brain Tunnelgenix Technologies Corp.™(btt™Corp.), of Bridgeport, CT, have established a partnership to deliver the first personal computer-based temperature monitoring system approved by the U.S. Food and Drug Administration. Specifically designed to be used during surgical procedures, in the recovery room, in intensive care and for general patient monitoring, the new Abreu btt™ 700 System for continuous temperature monitoring incorporates an ASUS Eee PC 1005HA as a key component.

The Abreu btt 700 System is the world’s first continuous and noninvasive device that measures temperature on the skin surface of the body with the highest thermoconductivity, the fat-free skin that overlies the Brain Temperature Tunnel (BTT), a new thermal organ in the body discovered in groundbreaking research by Dr. Marc Abreu of Yale University. 

“We feel privileged to be working closely with Brain Tunnelgenix Technologies on this revolutionary and proprietary product, which now gives the personal computer a major role in medical practice and improving patient care,” said Ben Thacker, Vice President, North America Systems Business Group, Sales & PMs. “We look forward to a long and mutually beneficial relationship with Brain Tunnelgenix Technologies Corp. and to further important and exciting technologies introduced by them.”

Brain Tunnelgenix Technologies Corp. Chief Executive Officer Rick Foreman sees a similar benefit from the partnership. “We are delighted that one of the tech industry’s leading innovators has partnered with us. ASUS has a well-earned reputation for unsurpassed reliability, and their first-class product will help preserve the health of countless patients and reduce the overall cost of patient care.”

To see the Abreu btt™ 700 System incorporating the ASUS Eee PC 1005HA, please visit the San Diego Convention Center, Booth 3815, from Oct 16-18. 

ASUS Eee PCs

In 2007, ASUS changed the PC industry with the introduction of the Eee PC, the original netbook.  Used by the thousands in health care facilities, schools, and homes, the Eee PC makes it easy to learn, work and play. Many Eee PCs carry EPEAT certification, and ASUS is regularly recognized as the most reliable brand for notebooks and netbooks in the major reliability studies, including those by Squaretrade and Rescuecom.*  To see ASUS’ full lineup of Eee PCs for health care and other commercial segments, please visit http://commercial.asus.com/category/index/17.


About ASUS

ASUS is a leading innovator in personal computing products and a preferred supplier of technology products to the health care sector. The company offers a broad portfolio of products that includes notebooks, netbooks, motherboards, graphics cards, displays, servers, multimedia, wireless solutions, and networking devices. Driven by innovation and committed to quality, ASUS won 3,268 awards in 2009, and is widely credited with revolutionizing the PC industry with the Eee PC™. With a global staff of more than 10,000 people and a world-class R&D team of 3,000 engineers, the company's revenue for 2009 was US $7.5 billion.

About Brain Tunnelgenix Technologies
Based on the groundbreaking discovery by Yale researcher Dr. Marc Abreu of the Brain Temperature Tunnel, a new thermal organ in the body, Brain Tunnelgenix Technologies Corp. (btt Corp.) has developed revolutionary technology that promises to transform human temperature measurement. Offering the first advancement in modern thermometry in 300 years, btt Corp. now makes it possible for human brain and core temperature to be noninvasively and continuously monitored, the same as other vital signs -- heart rate, blood pressure and respiratory rate. The company’s technologies are protected by a worldwide, multi-million dollar investment in patents, with more than 60 patents and patent applications in the U.S. and in more than 40 other countries, representing 85% of the world's purchasing power.  www.braintunnelgenix.com.

Media Contact for ASUS:   
Gary Key
ASUS Computer International
(817)-304-2271
Gary_key@asus.com 

Media Contact for Brain Tunnelgenix Technologies:      
Randy Savicky
Strategy+Communications
203-226-6156
randy@strategypluscommunications.com

Christine Johnston
Brain Tunnelgenix Technologies
203-870-9611
cjohnston@braintunnelgenix.com

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Message
Login to Submit Email

Author Info

Tag Cloud

Categories

More Releases

Comments

Add a Comment

    \n\